Evidence for a GABAergic control of the exercise-induced rise in GH in man
- PMID: 3930260
- DOI: 10.1007/BF00544075
Evidence for a GABAergic control of the exercise-induced rise in GH in man
Abstract
The effect of the GABAergic drug sodium valproate (SV) on the exercise-induced release of growth hormone (GH) was investigated in 10 healthy males. The exercise test consisted of using a stationary bicycle ergometer at 450 kg/min for 20 min. SV 600 mg blunted the increase in GH induced by the exercise, suggesting GABAergic regulation of GH secretion in man, at least under certain physiological conditions.
Similar articles
-
Impaired growth hormone response to sodium valproate in normal aging.Psychopharmacology (Berl). 1987;91(1):10-3. doi: 10.1007/BF00690918. Psychopharmacology (Berl). 1987. PMID: 3029790 Clinical Trial.
-
Pharmacological evidence for a dual GABAergic regulation of growth hormone release in humans.Life Sci. 1986 Sep 15;39(11):979-85. doi: 10.1016/0024-3205(86)90286-9. Life Sci. 1986. PMID: 3091975 Clinical Trial.
-
Opioid modulation of the gamma-aminobutyric acid-controlled inhibition of exercise-stimulated growth hormone and prolactin secretion in normal men.Eur J Endocrinol. 1994 Jul;131(1):50-5. doi: 10.1530/eje.0.1310050. Eur J Endocrinol. 1994. PMID: 8038904 Clinical Trial.
-
Growth hormone response to sodium valproate in chronic schizophrenia.Biol Psychiatry. 1986 Jun;21(7):588-94. doi: 10.1016/0006-3223(86)90119-8. Biol Psychiatry. 1986. PMID: 3085738 Clinical Trial.
-
The effect of methysergide, pimozide, and sodium valproate on the diazepam-stimulated growth hormone secretion in man.J Clin Endocrinol Metab. 1979 Jan;48(1):119-22. doi: 10.1210/jcem-48-1-119. J Clin Endocrinol Metab. 1979. PMID: 370137
Cited by
-
Impaired growth hormone response to sodium valproate in normal aging.Psychopharmacology (Berl). 1987;91(1):10-3. doi: 10.1007/BF00690918. Psychopharmacology (Berl). 1987. PMID: 3029790 Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources